New Intraoperative Imaging Tools and Image-Guided Surgery in Gastric Cancer Surgery.
Luise KnospeInes GockelBoris Jansen-WinkelnRené ThiemeStefan NiebischYusef MoullaSigmar StelznerOrestis LyrosMichelle DianaJacques MarescauxClaire ChalopinHannes KöhlerAnnekatrin PfahlMarianne MatkabiJi-Hyeon ParkHan-Kwang YangPublished in: Diagnostics (Basel, Switzerland) (2022)
Innovations and new advancements in intraoperative real-time imaging have gained significant importance in the field of gastric cancer surgery in the recent past. Currently, the most promising procedures include indocyanine green fluorescence imaging (ICG-FI) and hyperspectral imaging or multispectral imaging (HSI, MSI). ICG-FI is utilized in a broad range of clinical applications, e.g., assessment of perfusion or lymphatic drainage, and additional implementations are currently investigated. HSI is still in the experimental phase and its value and clinical relevance require further evaluation, but initial studies have shown a successful application in perfusion assessment, and prospects concerning non-invasive tissue and tumor classification are promising. The application of machine learning and artificial intelligence technologies might enable an automatic evaluation of the acquired image data in the future. Both methods facilitate the accurate visualization of tissue characteristics that are initially indistinguishable for the human eye. By aiding surgeons in optimizing the surgical procedure, image-guided surgery can contribute to the oncologic safety and reduction of complications in gastric cancer surgery and recent advances hold promise for the application of HSI in intraoperative tissue diagnostics.
Keyphrases
- fluorescence imaging
- minimally invasive
- machine learning
- coronary artery bypass
- artificial intelligence
- high resolution
- deep learning
- big data
- photodynamic therapy
- surgical site infection
- endothelial cells
- magnetic resonance imaging
- percutaneous coronary intervention
- robot assisted
- computed tomography
- lymph node
- mass spectrometry
- prostate cancer
- coronary artery disease
- quality improvement
- risk factors
- radical prostatectomy
- thoracic surgery